Cannabist Stock
StockStockPrice
Frequently asked questions
What is Cannabist's market capitalization?
What is the Earnings Per Share (EPS) for Cannabist?
What are the analyst ratings and target price for Cannabist's stock?
What is Cannabist's revenue over the trailing twelve months?
What is the EBITDA for Cannabist?
What is the free cash flow of Cannabist?
What is the 5-year beta of Cannabist's stock?
How many employees does Cannabist have, and what sector and industry does it belong to?
What is the free float of Cannabist's shares?
Financials
Market Cap
$54.70M5Y beta
1.61EPS (TTM)
-$0.298Free Float
419.70MRevenue (TTM)
$489.89MEBITDA (TTM)
$63.25MFree Cashflow (TTM)
-$24.09MPricing
Analyst Ratings
The price target is $1.171 and the stock is covered by 8 analysts.
Buy
6
Hold
2
Sell
0
Information
The Cannabist Company Holdings Inc. is a cultivator, manufacturer and provider of cannabis products and related services, with operations in 13 United States jurisdictions. The Company’s principal business activity is the production and sale of cannabis as regulated by the regulatory bodies and authorities of the jurisdictions in which it operates. The Company operates approximately 95 facilities, including 73 dispensaries and 22 cultivation and manufacturing facilities, including those under development. The Company is a multi-state provider of cannabis in the United States and delivers products and services to both the medical and adult-use markets. Its retail brand, Cannabist, creates a national dispensary network that leverages proprietary technology platforms. The Company offers products spanning flower, edibles, oils and tablets, and manufactures brands, including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber.
2,191
Crops
Health Care
Identifier
ISIN
Primary Ticker